Loading
Loading…
New: tenders and results on WhatsApp
New: Find tenders, results and companies on WhatsApp, by text or voice note
New: tenders and results on WhatsApp
New: Find tenders, results and companies on WhatsApp, by text or voice note
Loading…
Ref. No.
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Schedule | Awardee / L1 Bidder | Status | Bids | Value |
|---|---|---|---|---|---|
| 1 | Schedule 1 | SAARANSH BIOTECH PRIVATE LIMITEDLikely | RA Ended | 1 | ₹2.4 L |
| 2 | Schedule 2 | SAARANSH BIOTECH PRIVATE LIMITEDLikely | RA Ended | 1 | ₹4.5 L |
| 3 | Schedule 3 | AARAV PHARMACEUTICALS | Awarded | 1 | ₹2.3 L |
| 4 | Schedule 4 | SAARANSH BIOTECH PRIVATE LIMITED | Awarded | 1 | ₹94,500 |
| 5 | Schedule 5 | SAARANSH BIOTECH PRIVATE LIMITEDLikely | RA Ended | 1 | ₹2.6 L |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
1 Aug 2025, 4:00 pmClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
DOLUTEGRAVIR 50MG TAB
TAB TENOFOVIR 300 MG LAMIVUDINE 300 MG plus TAB DOLUTEGRAVIR 50 MG
Tab Tenofovir Alafenamide 25 mg Plus Emtricitabine 200 mg Plus Bictagravir 50 mg
TENOFOVIR 300 Plus EMTRICITABINE 200MG Plus EFAVIRENZE 600MG Tab
Tenofovir 300 mg plus Lamivudine 300 mg plus Efavirenz 400 mg Tab
TENOFOVIR 300MG plus LAMIVUDINE 300MG plus EFAVIRENZE 600MG Tab
TAB TENOFOVIR 300 plus TAB LAMIVUDINE 300MG
TAB TENOFOVIR ALAFENDAMIDE 25 MG plus TAB EMITRICITABINE 200 MG
Tab Tenofovir alfenamide 25 mg plus Emitricitabine 200 mg plus Tab Dolutegravir 50 mg
CRYPTOCOCCOL ANTIGEN LATERAL FLOW ASSAY Box of 20 Kits
TAB ABACAVIR 600MG plus TAB LAMIVUDINE 300MG
TAB DARUNAVIR 600 MG plus TAB RITONAVIR 100 MG
Darunavir 800 mg plusRitonovavir 100 mg Tab
Efavirenz 600 mg Tab
LAMIVUDINE 150MG plus ZIDOVUDINE 300MG plus NEVERAPINE 200MG Tab Bid Number : GEM/2025/B/6458435 Dated : 22-07-2025 Bid Document 1/18
8095697
GEM/2025/B/6458435
Two Packet Bid
DOLUTEGRAVIR 50MG TAB
30 days
Delhi; South West, Delhi; South West Delhi
Item wise evaluation
BOQ
8 documents required · 8 mandatory
3 yrs
₹17 L
₹68 L
80%
Exempted
1 Aug 2025
22 Jul 2025
1 Aug 2025
| Item No | Item Title | Description | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|---|
| 1 | DOLUTEGRAVIR 50MG TAB | as per BOQ att | 36,000 | No | SOUTH WEST DELHI | 30 |
| 2 | TAB TENOFOVIR 300 MG LAMIVUDINE 300 MG plus TAB DOLUTEGRAVIR 50 MG | as per BOQ att | 36,000 | No | SOUTH WEST DELHI | 30 |
| 3 | Tab Tenofovir Alafenamide 25 mg Plus Emtricitabine 200 mg Plus Bictagravir 50 mg | as per BOQ att | 6,000 | No | SOUTH WEST DELHI | 30 |
| 4 | TENOFOVIR 300 Plus EMTRICITABINE 200MG Plus EFAVIRENZE 600MG Tab | as per BOQ att | 6,000 | No | SOUTH WEST DELHI | 30 |
| 5 | Tenofovir 300 mg plus Lamivudine 300 mg plus Efavirenz 400 mg Tab | as per BOQ att | 19,800 | No | SOUTH WEST DELHI | 30 |
| 6 | TENOFOVIR 300MG plus LAMIVUDINE 300MG plus EFAVIRENZE 600MG Tab | as per BOQ att | 12,000 | No | SOUTH WEST DELHI | 30 |
| 7 | TAB TENOFOVIR 300 plus TAB LAMIVUDINE 300MG | as per BOQ att | 18,000 | No | SOUTH WEST DELHI | 30 |
| 8 | TAB TENOFOVIR ALAFENDAMIDE 25 MG plus TAB EMITRICITABINE 200 MG | as per BOQ att | 9,000 | No | SOUTH WEST DELHI | 30 |
| 9 | Tab Tenofovir alfenamide 25 mg plus Emitricitabine 200 mg plus Tab Dolutegravir 50 mg | as per BOQ att | 24,000 | No | SOUTH WEST DELHI | 30 |
| 10 | CRYPTOCOCCOL ANTIGEN LATERAL FLOW ASSAY Box of 20 Kits | as per BOQ att | 9 | Box | SOUTH WEST DELHI | 30 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_8095697.pdf
GEM_BID
docscanner_16-jul-2025_12-51_pm_2025-07-16-13-00-54_03a76deaf0dec14cb41177ae6bddba2e.pdf
BOQ
boq_item_sample_file-2_2025-07-16-13-00-54_678c0d7a6a38c6bd639c396016cb00f5.csv
BOQ
ATCforRE_29838210-0471-4ce2-a1121752651617571_ECHS@Procurement.docx
OTHER
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .